Navigation Links
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Date:11/2/2009

HOUSTON - Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

The findings, published today online in the Journal of Clinical Oncology, is the first large study to analyze this cohort and represents a shift in the way women with early-stage HER2 positive breast cancer should be assessed for risk of recurrence and considered for treatment, said the study's senior author, Ana M. Gonzalez-Angulo, M.D, associate professor in M. D. Anderson's Departments of Breast Medical Oncology and Systems Biology.

The research was first presented at the CRTC-AACR San Antonio Breast Cancer Symposium in December, 2008.

Herceptin, also known as trastuzumab, was approved for use in 1998 for women whose advanced breast cancer expresses Human Epidermal growth factor Receptor 2, or HER2. Approximately 15-20 percent of breast cancer cells produce an excess amount of the HER2 growth protein on their surface, which makes the cancer more aggressive. Herceptin is a monoclonal antibody that latches on to these proteins and inhibits tumor growth.

"This study represents a current debate within clinical practice - the risk of recurrence for early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller," said Gonzalez-Angulo. "Our findings show that women with early stage HER2 positive breast cancer have a 23 percent chance of recurrence. In contrast, the five-year survival rate of all women with such early-stage breast cancer is more than 90 percent.

"The findings indicate that physicians need to consider offering these women Herceptin-based therapy in the post-operative, or adjuvant setting," Gonzalez-Angulo continued.

Current guid
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. If Herceptin is Approved in Combination With Other Emerging Therapies it Will be in a Position to Retain Patient Share From Tykerb/Tyverb for the Treatment of HER2-Positive Breast Cancer
2. Early stage, HER2-positive breast cancer patients at increased risk of recurrence
3. Anthracyclines improve survival in HER2-positive breast cancer patients
4. Adapting space-industry technology to treat breast cancer
5. Company C Donates $40,000 To Fight Breast Cancer
6. Metropolitan Chicago Breast Cancer Task Force Announced Members of Chicago Breast Cancer Quality Consortium
7. 4th Annual Henry Schein Think Pink, Practice Pink Campaign Coincides With Breast Cancer Awareness Month
8. Cancer Centers of North Carolina Offers New 5-Day Breast Cancer Therapy
9. Gastroenterologists explore relationship between bacteria in the gut and breast cancer
10. Meditation May Reduce Stress in Breast Cancer Patients
11. Beaumont, U-M Open Study of Drug for Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today announced the ... natural blue food coloring. Construction of the plant, which is located on the ... began in May 2014. After commissioning, commercial production is expected to begin in ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... enterprise of Hospital Corporation of America (HCA), as it further expands its Strategic ... today. , With this new partnership, OncLive’s editorial and marketing teams will ...
(Date:7/1/2015)... ... , ... The 28th annual Charity Horse Show hosted by the Mid-South Horse ... p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth ... impersonator, a silent auction and concessions. , Horses and riders from around the country ...
(Date:7/1/2015)... ... 01, 2015 , ... “Well-meaning social policy often has unintended ... FIU’s School of International and Public Affairs. , The researchers examined ... National Survey on Drug Use and Health, which is a nationally representative survey ...
(Date:7/1/2015)... ... July 01, 2015 , ... Element Blue ™, ... today that it has received trademark protection for its SensorInsight® computer software platform. ... data from multiple sources providing an environment where users can view and compare ...
Breaking Medicine News(10 mins):Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4
... , UAN, Minnesota Nurses Point to Benefits for ... SPRING, Md., Oct. 15 A new Senate bill introduced ... the health and well-being of RNs in hospitals and other ... care they need, are transported and moved in the safest ...
... deverus, inc., a leading provider of software and ... today that Corporate Research and Investigations, LLC (CRI ... to provide an enterprise-level solution for its international ... and Investigations (Pvt.) Ltd., CRI Group excels at ...
... and designers, along with colleagues from other institutions, ... patients more in their diabetes treatment and medication ... cards, could help patients make decisions involving their ... results of this randomized trial are in September,s ...
... shot time could be counterproductive, researchers say , THURSDAY, Oct. ... normal and essential part of building an immune response, ... as Tylenol -- after a shot could dampen that response, ... means that a child,s immune system is processing the immunization, ...
... Agency also Announces Warning Letters Issued to LASIK ... The U.S. Food and Drug Administration today announced the ... Institute and the U.S. Department of Defense to examine ... In Situ Keratomileusis (LASIK), a surgical procedure that uses ...
... SILVER SPRING, Md., Oct. 15 The U.S. Food ... care when purchasing any products over the Internet that ... influenza virus. The warning comes after the FDA recently ... (oseltamivir), which may pose risks to patients. , (Logo: ...
Cached Medicine News:Health News:Nation's RNs Hail Sen. Franken's Support for Safe Patient Handling Measure 2Health News:deverus(TM) Expands Operations Overseas 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 2Health News:Mayo Clinic clinicians develop new decision aid tool to help type 2 diabetes patients 3Health News:Acetaminophen May Weaken Effectiveness of Kids' Vaccines 2Health News:FDA Announces Plans for LASIK Quality of Life Project 2Health News:FDA Announces Plans for LASIK Quality of Life Project 3Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 2Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 3
(Date:7/1/2015)... , July 1, 2015 Precyse, a ... education, announced today that, as part of its long ... agreement to be acquired by investment firm Pamplona Capital ... equity investors, Altaris Capital Partners and NewSpring Capital, have ... 1999, has assisted nearly 5,000 healthcare facilities and systems ...
(Date:7/1/2015)... July 1, 2015  Echo Therapeutics, Inc. (NASDAQ: ... on non-invasive continuous glucose monitoring and associated technologies, ... completely re-designed corporate website echotx.com . Echo,s ... Echo,s technology and enhances the quality and availability ... better communicates to prospective customers and stakeholders what ...
(Date:7/1/2015)... FT LAUDERDALE, Florida , July 1, 2015 /PRNewswire/ ... manufacturer and marketer of innovative medical devices for the treatment ... it prevailed in a final opposition appeal hearing in the ... 482 - STENT HAVING HELICAL ELEMENTS (,482). The ,482 patent ... and has been upheld as a valid patent in amended ...
Breaking Medicine Technology:Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 3Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2
... 2011 United Seating & Mobility (USM) is ... with Central Kentucky Mobility (CKM) to acquire and merge its ... Lexington, Louisville, as well as central, eastern and southern Kentucky. ... strengthens our position within a core market for us and ...
... users from Europe, Asia, the Middle East, North America ... Germany June 16-19 to participate in Elekta,s fifth European ... presentations and workshops given by Elekta users and company ... The Users, Conference was preceded by the Elekta Stereotactic ...
Cached Medicine Technology:Elekta European Users' Conference Attracts Top Minds in Cancer Management 2Elekta European Users' Conference Attracts Top Minds in Cancer Management 3
... Accutome Ultrasound Advent Pachymeter exceeds previous product ... ALK and other lamellar procedures, the measurement ... microns. High end range is 1000 microns ... care. Newly designed 55 angle probe ensures ...
Precision that fits in the palm of your hand and measures down to 125 microns, the Pocket Pachymeter is about 8" X 4" x 2" and really does fit in a lab coat pocket or briefcase....
15 segment Vertical Prism Bar provides 1, 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 18, 20, 25, 30 PD (Note: 30 PD is on the bar). 4447 xx Vertical Prism Bar....
Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: